Phase 2 proof of concept clinical trial in patients with cancer cachexia
Latest Information Update: 17 Feb 2015
At a glance
- Drugs VK 5211 (Primary)
- Indications Cachexia
- Focus Pharmacodynamics; Proof of concept
- Sponsors Viking Therapeutics
Most Recent Events
- 17 Feb 2015 New trial record